Save 75% - Only $49.99 for 1 full year! digitalPLUS subscription offer ends 12/1

Topics

Walter Reed National Military Medical Center
Profectus gets more investment for Ebola vaccine, from U.S. Army
Profectus gets more investment for Ebola vaccine, from U.S. Army

The U.S. Army is giving Profectus BioSciences $8.5 million to put toward human trials of the Ebola virus vaccine, bringing the Baltimore biotechnology company's fundraising total for the project to more than $17 million in a matter of days. Profectus had announced last week a grant worth up to $8.6 million for the vaccine from a branch of the U.S. Department of Health and Human Services. The company has drawn nearly $30 million in investment for the project since 2012, all but $5 million of it since the current Ebola outbreak began in West Africa. "Advancing this vaccine into human studies is a top priority for Profectus, and we remain committed to moving this program into...

Loading